The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant)Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer - Egyptian Knowledge Bank - troweb

5676

The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant)Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

The role of circulating tumor cells as a prognostic marker in the adjuvant setting of patients with breast cancer

Article

Predictive Role of Molecular Subtypes in Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Article

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

Article

Mammographic Breast Density as a Predictive Factor for Pathological and Clinical Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Article

The Impact of Neoadjuvant Chemotherapy on Breast Cancer

Article

Clinical Prognostic Factors in Breast Cancer

Article

The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor

Article

Circulating biomarkers of tumor invasiveness for diagnosis and prognosis of cancer metastasis

Article

Predictive and Prognostic Impact of Tumor-Infiltrating Lymphocytes (CD8+) In Breast Cancer Treated With Neoadjuvant Chemotherapy

Article

Role of Advanced MRI Techniques in Evaluating The Response of Breast Cancer to Neoadjuvant Chemotherapy